Foghorn Therapeutics annual operating margin
2020
2021
2022
2023
2024
2025
Foghorn Therapeutics Operating Margin Growth & History (FHTX)
Foghorn Therapeutics's operating margin was −279.49% for fiscal 2025.
View full Foghorn Therapeutics company overviewFoghorn Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −279.49% | +174.81 pp |
| 2024 | 2024-12-31 | −454.31% | −138.38 pp |
| 2023 | 2023-12-31 | −315.93% | +293.27 pp |
| 2022 | 2022-12-31 | −609.20% | +7027.95 pp |
| 2021 | 2021-12-31 | −7,637.15% | +8300.29 pp |
| 2020 | 2020-12-31 | −15,937.44% | — |
Foghorn Therapeutics quarterly operating margin
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −54.78% | +224.39 pp |
| Q1 2026 | 2026-03-31 | −660.33% | −275.37 pp |
| Q4 2025 | 2025-12-31 | −258.22% | +582.29 pp |
| Q3 2025 | 2025-09-30 | −226.92% | +78.56 pp |
| Q2 2025 | 2025-06-30 | −279.17% | +107.47 pp |
| Q1 2025 | 2025-03-31 | −384.96% | +173.33 pp |
| Q4 2024 | 2024-12-31 | −840.51% | −399.22 pp |
| Q3 2024 | 2024-09-30 | −305.48% | −207.75 pp |
| Q2 2024 | 2024-06-30 | −386.64% | +185.78 pp |
| Q1 2024 | 2024-03-31 | −558.30% | +69.26 pp |
| Q4 2023 | 2023-12-31 | −441.29% | +320.80 pp |
| Q3 2023 | 2023-09-30 | −97.73% | +328.24 pp |
| Q2 2023 | 2023-06-30 | −572.42% | +77.64 pp |
| Q1 2023 | 2023-03-31 | −627.56% | +81.73 pp |
| Q4 2022 | 2022-12-31 | −762.09% | +3176.48 pp |
| Q3 2022 | 2022-09-30 | −425.97% | +63625.25 pp |
| Q2 2022 | 2022-06-30 | −650.07% | +7687.21 pp |
| Q1 2022 | 2022-03-31 | −709.29% | +7378.13 pp |
| Q4 2021 | 2021-12-31 | −3,938.57% | +4339.92 pp |
| Q3 2021 | 2021-09-30 | −64,051.22% | −53722.17 pp |
| Q2 2021 | 2021-06-30 | −8,337.28% | — |
| Q1 2021 | 2021-03-31 | −8,087.41% | — |
| Q4 2020 | 2020-12-31 | −8,278.49% | — |
| Q3 2020 | 2020-09-30 | −10,329.05% | — |
Foghorn Therapeutics operating margin trends
Over the last five reported fiscal years, Foghorn Therapeutics's operating margin increased from −15,937.44% to −279.49%, a change of +15657.95 percentage points. The latest reported quarter, Q2 2026, shows −54.78%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Foghorn Therapeutics filings at SEC.gov ↗